Navigation Links
Repligen Reports Positive Phase 2 Clinical Trial Results of,Secretin for MRI Imaging of the Pancreas

pancreas in the U.S. each year that could benefit from the use of secretin."

Secretin is a natural gastrointestinal hormone involved in the process of digestion. Secretin has been used for many years by gastroenterologists in combination with endoscopy, an invasive procedure to evaluate and treat diseases of the pancreas and gallbladder. There are risks associated with the use of endoscopy, which have generated interest in the development of safer non-invasive tests to diagnose gastrointestinal disorders. The use of secretin in combination with a non-invasive procedure such as MRI to improve the detection and delineation of normal and abnormal structures of the pancreas and to quantify pancreatic fluid production, harnesses the natural biologic properties of the hormone to increase the diagnostic quality of the MRI image. The use of MRI is attractive for patient care as it can obviate the need for more risky invasive procedures.

The use of secretin in abdominal imaging may have application beyond improvements in detection of structural abnormalities. We are conducting several pilot studies to evaluate the use of secretin with MRI to assess among other things, the function of the pancreas. This study is based on the clinical observation that patients with pancreatic diseases have a reduced fluid production response to secretin stimulation and will be designed to confirm and quantify this observation. The Office of Orphan Products Development of the FDA granted Repligen orphan drug designation for RG1068, synthetic human secretin, for use with MRI of the pancreas. Orphan drug designation qualifies Repligen for seven years of exclusive marketing rights in the United States if the company is first to receive marketing approval for RG1068 for MRI imaging of the pancreas.

About Repligen Corporation

Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for diseases that affect the central nervous sy
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:7/31/2015)... According to a new market research report " ... Oxide, Filtration, E-beam, Gamma), Services (Onsite & Offsite), Consumables (Indicators, ... to 2020", published by MarketsandMarkets, The Sterilization Equipment Market is ... a CAGR of 7.6%.from 2015 to 2020. ... ables and 37 F igures ...
(Date:7/31/2015)... SAN DIEGO , July 31, 2015  Eisai ... Ltd. (Headquarters: Tokyo , President and ... Inc. (Headquarters: San Diego, California , ... HALO") have signed a clinical collaboration agreement to evaluate ... in combination with Halozyme,s investigational drug PEGPH20 (PEGylated recombinant ...
(Date:7/30/2015)... Mettler-Toledo International Inc. (NYSE: MTD ) ... are the highlights: , Sales in local ... prior year. Reported sales decreased 4% as currency reduced ... Net earnings per diluted share as reported (EPS) were ... EPS was $2.80 , an increase of 9% ...
Breaking Medicine Technology:Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 2Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14
... WALTHAM, Mass., Aug. 16 Interleukin Genetics, Inc. (OTCQB: ILIU) ... common stock will be transferred from the NYSE Amex ... Investors in the Company can trade the stock easily ... be ILIU.  The OTCQB market tier was recently introduced ...
... Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results -- BEIJING, Aug. 16 /PRNewswire-Asia-FirstCall/ -- ... ... --> ... = ,; var first_result; // Results are keyed by longUrl, so we need to grab the ...
Cached Medicine Technology:Interleukin Genetics Moves Trading of Stock to OTCQB Marketplace 2Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results 2Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results 3Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results 4Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results 5Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results 6Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results 7Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results 8Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results 9Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results 10Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results 11Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results 12
(Date:7/31/2015)... ... August 01, 2015 , ... The Honor Society of Nursing, Sigma Theta Tau ... of Nursing (GAPFON) 20-21 July 2015 in San Juan, Puerto Rico. Key nurse leaders ... Dr. Silvia Cassiani, Advisor, Nursing and Allied Health Personnel Development, Unit of Human Resources ...
(Date:7/31/2015)... ... ... Ticket Down is a reliable source for authentic tickets for the 2015 ... festival will end on Sunday, August 2nd. , Music fans have traveled ... unique and unbelievably popular festival attracts the best in entertainment from around the world. ...
(Date:7/31/2015)... ... 2015 , ... Recently touted by Becker’s Healthcare as one ... , Jvion continues to disrupt the predictive analytic and big data market using ... population level illness to drive prevention and better health outcomes. Most recently, Jvion ...
(Date:7/31/2015)... Tenn. (PRWEB) , ... July 31, 2015 , ... The ... Robert Church Park in Downtown Memphis on October 3, 2015. The Ride to Fight ... focused on cancer research between Methodist Healthcare, The West Clinic and The University of ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... There’s no ... possible, even when it comes time to cook the next meal, making July the ... July by practicing best grilling tips and recipes. , Make the next cookout different ...
Breaking Medicine News(10 mins):Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3
... -- Americans who were jobless for longer than 25 weeks ... those who were continuously employed to suffer mental health issues ... Being jobless also has a greater psychological impact on people ... with less education, the researchers found. The study involved ...
... help people with Parkinson,s disease improve their gait and balance, ... School of Nursing and Red Hill Studios, a California serious ... three-month research project showed small improvements in walking speed, balance ... the first research team in the United States to receive ...
... (Oct. 19, 2011) -- A review of the genetic ... link between the widely diagnosed neurological disorder and Type ... recent decades. "It appears that both Type 2 ... impaired glucose tolerance and hyperinsulinemia," said Rice University biochemist ...
... -- Men who get moderate amounts of exercise have better ... active, a new study finds. Motility refers to the ... important factor in fertility. The study by researchers at ... samples and information about their physical activity levels. The men ...
... solutions to dangerous water quality issues in refugee camps is ... High Commissioner for Refugees an agreement that will put ... lab and on the ground in Kenya, Uganda, Liberia and ... additional SMU funds, faculty member Andrew Quicksall and his graduate ...
... Society (ACS), the American Society for Colposcopy and Cervical ... (ASCP) have proposed new guidelines for the prevention and ... are now posted for public comment, generally advise that ... their lifetime to better ensure that they receive the ...
Cached Medicine News:Health News:Long-Term Unemployment Can Tax Mental Health 2Health News:Computer games help people with Parkinson's disease 2Health News:Research proposes common link between autism, diabetes 2Health News:Research proposes common link between autism, diabetes 3Health News:Sperm Moves Best for Moderate Exercisers: Study 2Health News:SMU scientists to lead water quality study at UN refugee camps 2Health News:SMU scientists to lead water quality study at UN refugee camps 3Health News:Health groups issue proposed cervical cancer screening guidelines 2Health News:Health groups issue proposed cervical cancer screening guidelines 3
The SL 115 Classic Slit Lamp offers you high optical performance and convenient operation. It is not only the ideal instrument for all routine examinations and contact lens fitting, but is also excel...
... The unparalleled Humphrey Lens Analyzers ... SPEXAN provide the most comprehensive lensometry ... the Humphrey Lens Analyzer (LA) gives ... for any lens-progressive lenses, prism lenses, ...
Lens Loading and Folding for Multipiece & Single-Piece ACRYSOF Lens with Standard Forceps...
... a plunger style advance, or a micrometer ... multiple use. The injector is made of ... cartridges. These injectors are sold sterile, and ... system was designed specifically for easy loading ...
Medicine Products: